VivoSeq
Other

Pediatric Disorder

1

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Pediatric Disorder is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Trihexyphenidyl

Wyeth-Lederle Vaccines

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

3

clinical trials

Completed1 · 33%
Active, not recruiting1 · 33%
Recruiting1 · 33%

Clinical Trials

Trial Activity

Umbilical Cord Blood Transplant for Congenital Pediatric Disorders
Completed·—·N/A·NCT00950846·40 enrolled
Marfan Syndrome: the Impact on the Quality of Life, Phenotypic Manifestations on Self-image and Self-management Skills, as an Index of Adaptation to the Disease in Pediatric Patients
Active, not recruiting·IIRCCS Policlinico S. Donato·N/A·NCT05748314·80 enrolled
Pharmacogenomic Contribution to the Biotransformation of Trihexyphenidyl and Development of a Precision Dosing Model for Children With Dystonia and Cerebral Palsy
Recruiting·CChildren's Mercy Hospital Kansas City·Phase 1·NCT06554288·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)